Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

73 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Insulin resistance and endothelial function are improved after folate and vitamin B12 therapy in patients with metabolic syndrome: relationship between homocysteine levels and hyperinsulinemia.
Setola E, Monti LD, Galluccio E, Palloshi A, Fragasso G, Paroni R, Magni F, Sandoli EP, Lucotti P, Costa S, Fermo I, Galli-Kienle M, Origgi A, Margonato A, Piatti P. Setola E, et al. Among authors: fermo i. Eur J Endocrinol. 2004 Oct;151(4):483-9. doi: 10.1530/eje.0.1510483. Eur J Endocrinol. 2004. PMID: 15476449 Clinical Trial.
Acute intravenous L-arginine infusion decreases endothelin-1 levels and improves endothelial function in patients with angina pectoris and normal coronary arteriograms: correlation with asymmetric dimethylarginine levels.
Piatti P, Fragasso G, Monti LD, Setola E, Lucotti P, Fermo I, Paroni R, Galluccio E, Pozza G, Chierchia S, Margonato A. Piatti P, et al. Among authors: fermo i. Circulation. 2003 Jan 28;107(3):429-36. doi: 10.1161/01.cir.0000046489.24563.79. Circulation. 2003. PMID: 12551867 Clinical Trial.
Beneficial effects of a long-term oral L-arginine treatment added to a hypocaloric diet and exercise training program in obese, insulin-resistant type 2 diabetic patients.
Lucotti P, Setola E, Monti LD, Galluccio E, Costa S, Sandoli EP, Fermo I, Rabaiotti G, Gatti R, Piatti P. Lucotti P, et al. Among authors: fermo i. Am J Physiol Endocrinol Metab. 2006 Nov;291(5):E906-12. doi: 10.1152/ajpendo.00002.2006. Epub 2006 Jun 13. Am J Physiol Endocrinol Metab. 2006. PMID: 16772327 Free article. Clinical Trial.
Genetic and clinical heterogeneity of ferroportin disease.
Cremonesi L, Forni GL, Soriani N, Lamagna M, Fermo I, Daraio F, Galli A, Pietra D, Malcovati L, Ferrari M, Camaschella C, Cazzola M. Cremonesi L, et al. Among authors: fermo i. Br J Haematol. 2005 Dec;131(5):663-70. doi: 10.1111/j.1365-2141.2005.05815.x. Br J Haematol. 2005. PMID: 16351644 Free article.
Hyperhomocysteinemia and venous thromboembolic disease.
D'Angelo A, Mazzola G, Crippa L, Fermo I, Viganò D'Angelo S. D'Angelo A, et al. Among authors: fermo i. Haematologica. 1997 Mar-Apr;82(2):211-9. Haematologica. 1997. PMID: 9175329 Review.
73 results